Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.
Clinical trial NCT03961659 · UNKNOWN
Trial details
- NCT number
- NCT03961659
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2020-08-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.